Clarus Therapeutics has finally gained FDA approval for Jatenzo, the first oral form of testosterone available in the United States. Previously, oral formulations of testosterone had been shown to cause liver toxicity. But, Jatenzo has been shown to successfully bypass the liver, instead entering the lymphatic system and then the blood circulation.
Jatenzo comes in several different dosages and is taken twice daily with food. Due to its frequent dosing, testosterone levels stay quite stable on treatment. This is an excellent treatment option for men who don’t want to perform weekly injections, or who haven’t responded well to topical treatments.